ACRX Old Insiders
| ACRXDelisted Stock | USD 1.01 0.01 1.00% |
ACRX Old employs about 19 people. The company is managed by 5 executives with a total tenure of roughly 35 years, averaging almost 7.0 years of service per executive, having 3.8 employees per reported executive. Break down of ACRX Old's management performance can provide insight into the company performance.
| Vincent Angotti CEO CEO, Interim CFO |
ACRX |
ACRX Old Management Team Effectiveness
The company has return on total asset (ROA) of (0.3222) % which means that it has lost $0.3222 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5112) %, meaning that it created substantial loss on money invested by shareholders. ACRX Old's management efficiency ratios could be used to measure how well ACRX Old manages its routine affairs as well as how well it operates its assets and liabilities.ACRX Old Workforce Comparison
ACRX Old is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 31,976. ACRX Old adds roughly 19.0 in number of employees claiming only tiny portion of equities under Health Care industry.
ACRX Old Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ACRX Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on ACRX Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ACRX Old insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Wan over a year ago Acquisition by Mark Wan of 581 shares of AcelRx Pharmaceuticals subject to Rule 16b-3 | ||
Three Arch Management Iv Llc over a year ago Exercise of in-the-money or at-the-money derivative position by Three Arch Management Iv Llc of 117661 shares of AcelRx Pharmaceuticals | ||
Three Arch Management Iv Llc over a year ago Exercise of in-the-money or at-the-money derivative position by Three Arch Management Iv Llc of 2597 shares of AcelRx Pharmaceuticals | ||
Mark Wan over a year ago AcelRx Pharmaceuticals exotic insider transaction detected |
ACRX Old Notable Stakeholders
An ACRX Old stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ACRX Old often face trade-offs trying to please all of them. ACRX Old's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ACRX Old's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vincent Angotti | CEO, Interim CFO | Profile | |
| Anil Dasu | Chief Officer | Profile | |
| Lawrence Hamel | Chief Devel. Officer | Profile | |
| Pamela MD | Chief CoFounder | Profile | |
| Raffi Asadorian | Chief Officer | Profile |
About ACRX Old Management Performance
The success or failure of an entity such as ACRX Old often depends on how effective the management is. ACRX Old management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ACRX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ACRX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California. Acelrx Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.
Please note, the imprecision that can be found in ACRX Old's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ACRX Old. Check ACRX Old's Beneish M Score to see the likelihood of ACRX Old's management manipulating its earnings.
ACRX Old Workforce Analysis
Traditionally, organizations such as ACRX Old use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ACRX Old within its industry.ACRX Old Manpower Efficiency
Return on ACRX Old Manpower
| Revenue Per Employee | 93.2K | |
| Revenue Per Executive | 354.2K | |
| Net Income Per Employee | 2.5M | |
| Net Income Per Executive | 9.6M | |
| Working Capital Per Employee | 568.2K | |
| Working Capital Per Executive | 2.2M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in ACRX Stock
If you are still planning to invest in ACRX Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACRX Old's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world |